How to Get Testosterone Enanthate in New Jersey

At a glance
- Drug / testosterone enanthate, Schedule III controlled substance
- Indication / male hypogonadism (low testosterone)
- Route / intramuscular injection, typically once weekly
- NJ telehealth prescribing / yes, fully legal for testosterone enanthate
- NJ 503A compounding / yes, licensed pharmacies may compound and ship within the state
- NJ Medicaid / covered with prior authorization
- Prescribers / MDs, DOs, NPs (with collaborative agreement), PAs (with supervising physician)
- Required labs / total testosterone, free testosterone, CBC, metabolic panel, PSA (men over 40)
- Typical time to first injection / 7 to 14 days from initial consult
- Manufacturer / multiple generic manufacturers available
New Jersey Law Permits Telehealth Testosterone Prescribing
New Jersey is one of the more accessible states for men seeking testosterone replacement therapy (TRT). State law allows licensed prescribers to evaluate patients and prescribe Schedule III controlled substances, including testosterone enanthate, via telehealth. This means a man in Trenton or Cape May can complete the entire prescribing process without stepping into a brick-and-mortar clinic.
How NJ Telehealth Prescribing Works
The New Jersey Division of Consumer Affairs confirmed during the post-pandemic regulatory update that audio-video telehealth visits satisfy the standard of care for ongoing prescriptions, including controlled substances, provided the prescriber holds a valid NJ medical license [1]. The prescriber must document a history and physical, confirm labs, and establish a legitimate provider-patient relationship before writing the prescription.
Choosing a Telehealth Platform
Several national men's health platforms and NJ-based endocrinology practices now offer virtual TRT consultations. When selecting a provider, verify that they order pre-treatment labs (not just a symptom questionnaire), that they hold a New Jersey medical license, and that they provide ongoing monitoring every 3 to 6 months. The Endocrine Society's 2018 clinical practice guideline recommends monitoring hematocrit, PSA, and testosterone levels at 3, 6, and 12 months after initiating therapy, then annually [2].
Who Can Prescribe Testosterone Enanthate in New Jersey
Not every healthcare professional in NJ holds prescriptive authority for Schedule III substances. Understanding the prescriber hierarchy helps you choose the right provider.
MDs and DOs
Physicians (MDs and DOs) licensed in New Jersey have full, independent authority to prescribe testosterone enanthate. Endocrinologists, urologists, and primary care physicians are the most common prescribers. A 2020 analysis published in The Journal of Clinical Endocrinology & Metabolism found that primary care providers wrote 60.2% of all testosterone prescriptions in the United States, while urologists and endocrinologists accounted for 14.8% and 4.1%, respectively [3].
Nurse Practitioners
New Jersey NPs gained full practice authority under Senate Bill 2109, signed into law in 2019, which removed the requirement for a collaborative agreement after a specified transition period [4]. NPs with prescriptive authority can prescribe testosterone enanthate independently once they meet the state's experience requirements. For NPs still in the supervised period, a collaborative agreement with a physician must be on file.
Physician Assistants
PAs in New Jersey prescribe under a supervising physician's delegated authority. A PA can write a testosterone enanthate prescription provided the supervising physician's agreement explicitly includes Schedule III controlled substances. The PA must also hold a valid DEA registration and NJ CDS registration.
Required Lab Work Before Starting Testosterone Enanthate
No responsible prescriber will write a testosterone enanthate prescription without baseline laboratory data. Labs serve two purposes: confirming the diagnosis of hypogonadism and screening for contraindications.
Diagnostic Labs
The Endocrine Society guideline defines male hypogonadism as a total testosterone level below 300 ng/dL measured on two separate morning samples [2]. Free testosterone, calculated or measured by equilibrium dialysis, adds diagnostic precision, particularly in men with obesity or altered sex hormone-binding globulin (SHBG). The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies enrolling 790 men aged 65 and older with testosterone levels below 275 ng/dL, demonstrated that testosterone gel improved sexual function, physical activity, and mood over 12 months compared to placebo [5].
Safety Screening Labs
Before the first injection, expect a complete blood count (CBC) with hematocrit, comprehensive metabolic panel (CMP), lipid panel, and PSA for men over 40. The FDA-approved label for testosterone enanthate lists polycythemia (hematocrit above 54%) as a risk requiring dose adjustment or discontinuation [6]. A baseline hematocrit gives the prescriber a reference point for future monitoring.
The HealthRX Pre-TRT Lab Checklist
A structured approach prevents missed labs. The minimum panel includes: total testosterone (two morning draws), free testosterone or SHBG, CBC with differential, CMP, lipid panel, LH and FSH (to differentiate primary from secondary hypogonadism), estradiol, and PSA (age 40+). Prolactin testing is added when testosterone is below 150 ng/dL or when secondary hypogonadism is suspected.
503A Compounding Pharmacies in New Jersey
New Jersey licenses 503A compounding pharmacies under the State Board of Pharmacy. These pharmacies can prepare patient-specific testosterone enanthate formulations when a valid prescription exists.
What 503A Means for You
A 503A pharmacy compounds a medication in response to an individual prescription. This differs from 503B outsourcing facilities, which produce large batches without patient-specific prescriptions. For testosterone enanthate, 503A compounding is relevant when a patient needs a non-standard concentration, a different carrier oil (for patients allergic to sesame or cottonseed oil), or when brand-name or generic commercial products face supply disruption.
In-State Shipping Rules
New Jersey 503A pharmacies may ship compounded testosterone enanthate directly to patients within the state. However, cross-state shipping is governed by the receiving state's regulations. If you are a NJ resident using a 503A pharmacy in another state, confirm that the pharmacy holds a nonresident license in New Jersey. The National Association of Boards of Pharmacy (NABP) maintains a database of verified pharmacy licenses [7].
Cost Comparison
Commercially manufactured testosterone enanthate 200 mg/mL in a 5 mL multi-dose vial typically costs $30 to $90 at retail pharmacies with a GoodRx-type discount. Compounded testosterone enanthate from a 503A pharmacy ranges from $40 to $120 for a similar supply, depending on the formulation and carrier oil. Compounding may cost slightly more, but it offers formulation flexibility that commercial products cannot match.
Insurance Coverage and NJ Medicaid
Paying out of pocket is one option, but many New Jersey residents have insurance that covers testosterone enanthate for the approved indication of male hypogonadism.
NJ Medicaid Coverage
New Jersey Medicaid covers testosterone enanthate for male hypogonadism with prior authorization (PA). The PA process requires the prescriber to submit documentation showing: a confirmed diagnosis of hypogonadism (ICD-10 code E29.1), two morning testosterone levels below 300 ng/dL, and absence of contraindications such as untreated prostate cancer or a hematocrit above 54% [6]. Expect a 5- to 10-business-day turnaround for PA decisions. If denied, the prescriber can submit a peer-to-peer review or formal appeal.
Commercial Insurance
Most commercial plans in New Jersey, including Horizon Blue Cross Blue Shield, Aetna, and UnitedHealthcare, cover generic testosterone enanthate as a Tier 2 or Tier 3 medication. Step therapy requirements are uncommon for injectable testosterone, but some plans may require documentation that the patient tried topical testosterone (gel or patch) first. The AUA/Endocrine Society consensus statement notes that injectable testosterone enanthate and cypionate remain the most cost-effective formulations for long-term TRT [8].
What Prior Authorization Documentation Looks Like
A standard PA packet includes: the patient's two qualifying testosterone levels with dates and lab reference ranges, a letter of medical necessity from the prescriber, the specific ICD-10 diagnosis code, relevant history (symptoms of hypogonadism such as fatigue, decreased libido, or loss of lean mass), and any prior treatment trials. Dr. Shalender Bhasin, lead author of the Endocrine Society's 2018 guideline, stated: "Testosterone therapy should be offered to men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" [2].
Timeline: Consultation to First Injection
Speed matters when symptoms of hypogonadism affect daily life. Here is a realistic timeline for a New Jersey patient.
Days 1 to 3: Initial Consultation and Lab Orders
The first telehealth or in-person visit takes 20 to 40 minutes. The provider orders labs, which most patients complete at a Quest Diagnostics or LabCorp draw site within one to two days. New Jersey has over 200 Quest and LabCorp locations statewide [9].
Days 4 to 7: Lab Review and Prescription
Lab results typically return within 48 to 72 hours. If two qualifying testosterone levels are on file and the safety panel is clear, the prescriber writes the testosterone enanthate prescription. For telehealth patients, this second visit (the lab review) is often a brief 10- to 15-minute follow-up.
Days 7 to 14: Pharmacy Fill and First Injection
A retail or mail-order pharmacy fills the prescription within one to three business days. If the patient uses a 503A compounding pharmacy, allow three to five business days for compounding and shipping. The prescriber or a nurse demonstrates the intramuscular injection technique during a brief in-person or video visit. Many TRT patients self-inject at home after this initial training.
The total time from first consultation to first injection is 7 to 14 days for most patients. Delays occur when insurance requires prior authorization (add 5 to 10 business days) or when a second morning testosterone draw is needed.
Transferring a Testosterone Enanthate Prescription to New Jersey
If you are relocating to New Jersey or splitting time between states, you can transfer an existing testosterone enanthate prescription under certain conditions.
In-State Transfer
Transferring between two New Jersey pharmacies is straightforward. Call the new pharmacy, provide the prescription details and the originating pharmacy's name and phone number, and the pharmacist initiates the transfer. Schedule III controlled substance prescriptions can be transferred once under federal law, unless the prescription was written in a state that participates in an electronic transfer system [10].
Out-of-State Transfer
New Jersey accepts transfers of controlled substance prescriptions from other states, but the receiving NJ pharmacist must verify the prescription's validity and the prescriber's license. If the original prescriber is not licensed in New Jersey, you will need a new prescription from a NJ-licensed provider. This is where telehealth is particularly useful: a virtual visit with a NJ-licensed prescriber, combined with recent lab work (within the past 6 months), can generate a new prescription quickly.
Ongoing Monitoring and Follow-Up
Starting testosterone enanthate is not a one-time event. The Endocrine Society recommends follow-up labs at 3, 6, and 12 months, then annually [2]. Hematocrit is the most important safety marker. A retrospective cohort study of 5,695 men on testosterone therapy found that 11.2% developed a hematocrit above 50% within the first year, with 1.6% exceeding 54% and requiring intervention [11].
What Gets Checked at Each Visit
At 3 months: total testosterone (trough level, drawn just before the next injection), hematocrit, and symptom assessment. At 6 months: repeat testosterone, CBC, and liver function tests. At 12 months: full panel including lipids, PSA (if applicable), estradiol, and bone density assessment if clinically indicated. The FDA label recommends checking hematocrit at baseline, at 3 to 6 months, then annually [6].
Dose Adjustments
The standard starting dose of testosterone enanthate is 100 to 200 mg intramuscularly every 7 to 14 days [6]. Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has noted: "The goal of testosterone therapy is to bring levels into the mid-normal range, typically 400 to 700 ng/dL, while keeping hematocrit below 54%" [12]. Dose titration is based on trough testosterone levels and symptom response, not peak values drawn 24 to 48 hours after injection.
Avoiding Common Pitfalls in New Jersey
Beware of No-Lab Clinics
Any provider who offers testosterone without lab work is cutting corners. The Endocrine Society guideline is explicit: "We recommend against starting testosterone therapy in patients who are planning fertility in the near term" and "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs consistent with testosterone deficiency and unequivocally and consistently low serum testosterone concentrations" [2]. A clinic that skips labs cannot confirm the diagnosis or screen for contraindications.
Controlled Substance Monitoring
New Jersey participates in the Prescription Monitoring Program (NJ PMP), which tracks all Schedule II through V controlled substance dispensing [13]. Prescribers must check the PMP before writing a testosterone enanthate prescription. This is a safeguard, not a barrier. It protects patients from duplicate prescriptions and potential drug interactions.
Supply Chain Awareness
Generic testosterone enanthate has experienced intermittent shortages over the past several years. The FDA Drug Shortages Database lists periodic supply disruptions from various manufacturers [14]. If your pharmacy cannot fill a testosterone enanthate prescription, ask whether testosterone cypionate (a pharmacologically equivalent ester) is available, or consider a 503A compounding pharmacy as a backup source.
Frequently asked questions
›How do I get a testosterone enanthate prescription in New Jersey?
›What labs are needed before testosterone enanthate in New Jersey?
›Are there telehealth providers in New Jersey prescribing testosterone enanthate?
›How long until I receive testosterone enanthate in New Jersey?
›Can I transfer a testosterone enanthate prescription to New Jersey?
›Are 503A pharmacies in New Jersey licensed to ship testosterone enanthate?
›Who can prescribe testosterone enanthate in New Jersey: MD vs NP vs PA?
›What documentation does prior authorization require in New Jersey?
›What is the typical dose of testosterone enanthate?
›Does NJ Medicaid cover testosterone enanthate?
›Can I self-inject testosterone enanthate at home in New Jersey?
›How often do I need follow-up labs on testosterone enanthate?
References
- New Jersey Division of Consumer Affairs. Telemedicine and telehealth regulations. https://www.njconsumeraffairs.gov/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Baillargeon J, Urban RJ, Morgentaler A, et al. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med. 2013;173(15):1465-1466. https://pubmed.ncbi.nlm.nih.gov/23939517/
- New Jersey Legislature. Senate Bill 2109: Advanced Practice Nurse full practice authority. 2019. https://www.njleg.state.nj.us/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- U.S. Food and Drug Administration. Testosterone enanthate injection prescribing information. https://www.accessdata.fda.gov/
- National Association of Boards of Pharmacy. Verified pharmacy license database. https://nabp.pharmacy/
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29990858/
- Quest Diagnostics. Patient service center locator. https://www.questdiagnostics.com/
- U.S. Drug Enforcement Administration. Pharmacist manual: transfer of controlled substance prescriptions. https://www.deadiversion.usdoj.gov/
- Ohlander SJ, Varghese B, Ganjoo SS, et al. Erythrocytosis following testosterone therapy. Sex Med Rev. 2018;6(1):77-85. https://pubmed.ncbi.nlm.nih.gov/28526632/
- Morgentaler A. Testosterone and prostate cancer: an historical perspective on a modern myth. Eur Urol. 2006;50(5):935-939. https://pubmed.ncbi.nlm.nih.gov/16875775/
- New Jersey Division of Consumer Affairs. NJ Prescription Monitoring Program. https://www.njconsumeraffairs.gov/pmp
- U.S. Food and Drug Administration. FDA drug shortages database. https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages